Search the Newsreel

Is VLTO Worth Buying as Growth Improves but Valuation Stays Rich?

Veralto Corporation (VLTO) exhibits strong earnings momentum, resilient recurring revenues, and ample liquidity, leading management to anticipate accelerated growth through 2026. However, its valuation remains significantly higher than industry benchmarks, and its long-term growth profile is considered measured. While the company's operational progress supports …

Molson Coors (NYSE:TAP) Reports Q2 CY2026 In Line With Expectations

Molson Coors (NYSE:TAP) Reports Q2 CY2026 In Line With Expectations Beer company Molson Coors (NYSE:TAP) met Wall Street's revenue expectations in Q2 CY2026, but sales fell by 3.3% year on year to $3.10 billion. Its non-GAAP profit of $1.58 per share was 4.4% above …

VLTO Climbs 13.2% in 3 Months: Will Its Momentum Keep Building Now?

Veralto Corporation (VLTO) shares have increased 13.2% in the past three months, driven by improved earnings expectations and strong second-quarter results. The company's Water Quality segment showed significant growth, and management raised 2026 adjusted earnings and core sales guidance. While the operating outlook is …

Cetera Investment Advisers Reduces Stake in Veralto Corporation $VLTO

Cetera Investment Advisers reduced its stake in Veralto Corporation (NYSE:VLTO) by 30% in the first quarter of 2026, selling 17,065 shares and retaining 39,884 shares valued at $3.53 million. Despite this, institutional investors collectively own 91.28% of the company. Veralto reported strong Q2 earnings, …

LiveRamp Holdings (RAMP) Adds Meta Campaigns To Cross Media Measurement

LiveRamp Holdings (RAMP) has expanded its Cross-Media Intelligence solution to include Meta campaign data, providing marketers with a unified view across more channels. This integration aims to reduce fragmented reporting and duplicated measurement efforts by allowing brands to assess performance in one place. The …

LiveRamp Holdings, Inc. 2026: Revenue $213.99M, EPS $0.28— 10-Q Summary

LiveRamp Holdings, Inc. reported strong Q1 2026 results with revenue reaching $213.99 million and diluted EPS at $0.28, significantly up from the previous year. This growth was fueled by increases in Subscription and Marketplace segments, along with a robust international performance. The company also …

Molson Coors' Q2 GAAP Pretax Income Drops 49% to $283.1M

Molson Coors Brewing (TAP) Surpasses Q2 Earnings and Revenue Estimates

Verastem (Nasdaq: VSTM) lifts Q2 2026 revenue to $40M, discloses going‑concern risk

Molson Coors Beverage (NYSE:TAP) Releases FY 2026 Earnings Guidance

Molson Coors Beverage (TAP) Earnings Date and Reports 2026 $TAP

Price to sales forward of Veradermics, Incorporated – NYSE:MANE

This article provides a brief financial overview for Veradermics, Incorporated (NYSE: MANE), specifically focusing on its price-to-sales forward metric. It appears to be a snapshot from a financial data platform, indicating that the market is closed and no trades have occurred for the company. …

BlackRock, Inc. Trims Verastem Inc (VSTM) Stake in Recent 13DG Filing

BlackRock, Inc. has reduced its stake in Verastem Inc (VSTM) by 7,913 shares, a 0.13% decrease, as disclosed in a recent 13G filing. The biopharmaceutical company, specializing in anticancer agents, faces significant financial and operational challenges, reflected in its low GF-Score and weak profitability …

LiveRamp (NYSE:RAMP) Announces Quarterly Earnings Results

Eastroc Beverage Boosts Hua Xia Wealth Product Holdings in Discloseable Transaction

Eastern Bank Sells 209,635 Shares of Veralto Corporation $VLTO

Eastern Bank significantly reduced its stake in Veralto Corporation (VLTO) by 82.7% in the second quarter, selling 209,635 shares but still holding 43,794 shares valued at $3.9 million. Other institutional investors like State Street Corp, Geode Capital Management LLC, First Trust Advisors LP, Invesco …

Results: Veracyte, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Veracyte, Inc. exceeded analyst expectations for its quarterly results, with revenues hitting US$150m and statutory EPS at US$0.31, 19% above forecasts. Following these positive results, analysts have slightly increased their earnings per share outlook for 2026, though the consensus revenue estimates remain largely unchanged. …

LiveRamp (NYSE:RAMP) Posts Q2 CY2026 Sales In Line With Estimates

LiveRamp (NYSE:RAMP) Posts Q2 CY2026 Sales In Line With Estimates Data collaboration platform LiveRamp (NYSE:RAMP) met Wall Street's revenue expectations in Q2 CY2026, with sales up 9.8% year on year to $214 million. Its non-GAAP profit of $0.65 per share was 9.2% above analysts' …

LiveRamp faces August 17 vote on Publicis buyout at $38.50 a share

LiveRamp reported Q1 fiscal 2027 revenue of $214.0 million, a 9.8% increase, and confirmed its shareholders will vote on the Publicis Groupe takeover on August 17, 2026, at $38.50 per share. The company suspended share repurchases and financial guidance due to the pending merger, …

Verastem, Inc. (VSTM) CEO sells 1,302 shares to cover RSU taxes

Verastem, Inc. CEO Dan Paterson sold 1,302 shares of common stock on August 3, 2026, at a price of $5.81 per share. This transaction was executed to fulfill statutory tax withholding requirements associated with the vesting of restricted stock units (RSUs) and was conducted …

LiveRamp Announces Results For First Quarter Fiscal 2027

LiveRamp, Inc. Revenue increased 10% year-over-year GAAP operating income more than doubled year-over-year and non-GAAP increased 41% Publicis Groupe transaction still expected to close before the end of CY26 SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), a leading data collaboration …

Equity awards for Vera Therapeutics (VERA) Chief Regulatory Officer

Vera Therapeutics (VERA) Chief Regulatory Officer, Nancy Lee Boman, received equity awards comprising 63,011 stock options with an exercise price of $32.23 and 44,987 restricted stock units (RSUs) under the company's 2024 Inducement Plan. These awards are subject to vesting schedules based on continuous …

Monster Beverage Seen Delivering 'Strong Quarter,' RBC Says

Monster Beverage (MNST) is expected to deliver another "strong quarter" as resilient energy-drink de PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …

Avoiding Lag: Real-Time Signals in (VLTO) Movement

Veralto Corp (NASDAQ: VLTO) is showing weak sentiment in the near-term and a broader long-term weak bias, despite mid-term strength. AI models have generated three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss parameters. The analysis indicates no …

Diamond Hill Is Betting on Veralto’s (VLTO) Resilient Business Model

Diamond Hill Capital has added Veralto Corporation (NYSE: VLTO) to its Mid Cap Strategy, believing the market undervalues its resilient business model, strong profitability, and disciplined capital allocation. Veralto, a water testing and treatment provider spun out of Danaher, was highlighted in Diamond Hill's …

RBC Capital reiterates Monster Beverage stock rating on strong outlook By Investing.com

RBC Capital has reaffirmed its Outperform rating for Monster Beverage (NASDAQ:MNST) with a $97 price target, citing a strong outlook and robust performance. The company has significantly outperformed the market, driven by top-line resilience in the energy drink category and easing commodity pressures, leading …

LiveRamp earnings in focus: Can AI push drive revenue beat?

LiveRamp Holdings Inc. is set to report fiscal first-quarter earnings, with analysts anticipating 60 cents per share on revenue of $211.74 million. Investors are keenly watching whether the company's significant push into AI will translate into stronger financial performance and accelerate growth. Key areas …

RBC Capital mantém recomendação de compra para ação da Monster Beverage - Investing.com Brasil

Veracyte (NASDAQ:VCYT) Shows Affordable Growth Potential

Arrowstreet Capital Limited Partnership Decreases Position in National Beverage Corp. $FIZZ

Arrowstreet Capital Limited Partnership reduced its stake in National Beverage Corp. (NASDAQ:FIZZ) by 37.5% in the first quarter, selling 48,193 shares and retaining 80,327 shares valued at $2.7 million. Despite exceeding revenue expectations, National Beverage reported quarterly EPS of $0.43, missing the consensus estimate …

Earnings call transcript: Monster Beverage Q1 2026 beats forecasts, stock dips

Monster Beverage reported record Q2 2026 net sales of $2.54 billion, a 20.2% year-over-year increase, driven by strong international growth and the Monster Energy drinks segment. Despite higher costs for aluminum, freight, and marketing, the company saw adjusted diluted EPS rise by 15.2% to …

LiveRamp (RAMP) Earnings Date and Reports 2026

[10-Q] LiveRamp Holdings, Inc. Quarterly Earnings Report

Veralto Corporation (NYSE:VLTO) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Veralto Corporation recently released its second-quarter results, showing revenues of US$1.5 billion and EPS of US$0.98, which were largely in line with analyst estimates. Analysts are forecasting US$5.90 billion in revenues for 2026 and US$4.08 in statutory EPS, with no significant changes to their …

VSTM|Verastem Inc|Price:5.695|Chg%:-0.105

Verastem Inc (VSTM) shows healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Biotechnology & Medical Research industry. Institutional ownership is notably high, and analysts currently rate the stock as a "Buy" with a target price indicating significant upside. …

VERACYTE INC : PIPER SANDLER CUTS TARGET PRICE TO $54.00 FROM $66.00

Piper Sandler has reduced its target price for VERACYTE INC (VCYT.O) to $54.00 from $66.00. This report was issued by Reuters on August 4, 2026. The article advises readers that its content reflects the author's opinion and should not be used as the sole …